In 2017, Lewwin Pharm successfully passed the evaluation by the Guangdong Provincial Department of Science and Technology and was officially designated by the provincial government as a New-type R&D Institute in Guangdong Province. A project was subsequently established to support the construction of the High-Level New-Type R&D Institute, thereby promoting the high-quality development of the institute.